1. A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE‐CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL). (June 2017) Authors: Locatelli, F.; Mauz‐Koerholz, C.; Neville, K.; Llort, A.; Beishuizen, A.; Daw, S.; Pillon, M.; Aladjidi, N.; Klingebiel, T.; Landman‐Parker, J.; Medina‐Sanson, A.; August, K.; Huebner, D.; Sachs, J.; Hoffman, K.; Kinley, J.; Song, S.; Song, G.; Zhang, S.; Gore, L. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines. (16th November 2016) Authors: Seror, E.; Donadieu, J.; Pacquement, H.; Abbou, S.; Lambilliotte, A.; Schell, M.; Curtillet, C.; Gandemer, V.; Pasquet, M.; Aladjidi, N.; Lutz, P.; Schmitt, C.; Deville, A.; Minckes, O.; Vanier, J P.; Armari-Alla, C.; Thomas, C.; Gorde-Grosjean, S.; Millot, F.; Blouin, P. Journal: Pediatric hematology and oncology Issue: Volume 33:Number 7/8(2016) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗